首页|溴己新注射剂临床配伍用药研究

溴己新注射剂临床配伍用药研究

Clinical compatibility of bromhexine injectable preparations

扫码查看
目的 考察导致溴己新注射剂临床输液药液混浊原因,为保障该注射剂质量和临床安全使用提供参考.方法 结合溴己新溶解度分析实验,开展代表性的临床配伍实验研究,关注非治疗性药物的配伍情况.结果 药液pH环境高度影响溴己新的溶解度,结合复方氯化钠注射液和复方电解制注射液的验证性临床配伍实验,溴己新注射剂临床配伍用药的环境pH偏碱性时易出现药液变混浊的不良状况.结论 溴己新注射液配伍后浑浊现象的关键影响因素为pH而非输液溶媒,提示非治疗性药物的临床配伍问题应予以重视.
Objective To investigate the causes of turbidity that occurs during infusion of bromhexine injectable preparations.Methods Representative clinical compatibility tests for verification were carried out in combination with bromhexine solubility analysis,and the relevant compatibility of non therapeutic drugs was observed.Results The solubility of bromhexine was highly correlated with the pH environment.Combined with confirmatory clinical compatibility tests of compound sodium chloride injection and multiple electrolytes injection,it was confirmed that bromhexine injectable preparations were likely to become turbid when the environmental pH value of the clinical compatibility medication was slightly alkaline.Conclusion The turbidity of bromhexine injectable preparations is chiefly due to pH rather than the infusion solvent,suggesting the need to attach importance to clinical compatibility of non-therapeutic drugs.

bromhexineinjectionclinical compatibilitysolubilitypHsodium chloride injectionnon therapeutic drugselectrolytessolvent

刘毅、刘晓强、姚晓、李选堂、郭贤辉、耿颖、裴宇盛

展开 >

中国食品药品检定研究院化学药品检定所,化学药品质量研究与评价重点实验室,北京 102629

江苏省常州市药品检验所,江苏 常州 213002

溴己新 注射剂 临床配伍 溶解度 酸碱度 氯化钠注射液 非治疗性药物 电解质 溶媒

中国食品药品检定研究院化学药品检定所重点实验室学科建设项目北京市自然科学基金资助项目

2023HYZX25L222010

2024

中国药物警戒
国家药品监督管理局药品评价中心(国家药品不良反应监测中心)

中国药物警戒

CSTPCD
影响因子:1.105
ISSN:1672-8629
年,卷(期):2024.21(8)